Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Sell
4,027
-13,023
-76% -$851K ﹤0.01% 833
2026
Q1
$781K Buy
+17,050
New +$985K ﹤0.01% 502
2025
Q4
Sell
-8,451
Closed -$618K 971
2025
Q3
$618K Buy
+8,451
New +$643K ﹤0.01% 445
2025
Q1
Sell
-4,477
Closed -$273K 686
2024
Q4
$273K Buy
+4,477
New +$249K ﹤0.01% 470
2023
Q3
Sell
-11,496
Closed -$176K 216
2023
Q2
$176K Hold
11,496
0.03% 208
2023
Q1
$130K Sell
11,496
-6,633
-37% -$83.6K 0.02% 241
2022
Q4
$175K Buy
+18,129
New +$273K 0.02% 237

Other funds holding AFRM

Marex Group's AFRM Position: Q2 2026 in Review

Marex Group reduced its Affirm (AFRM) stake by 76% in Q2 2026, selling an estimated $851K and leaving 4,027 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Marex Group first reported a position in AFRM in Q4 2022 and has held it in 7 quarters since. The position peaked at $781K in Q1 2026. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Marex Group held 4,027 shares of Affirm worth $328K as of Q2 2026.
  • Marex Group sold 13,023 Affirm shares in Q2 2026, an estimated $851K.
  • Affirm made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #833 holding.
  • Marex Group first reported a position in Affirm in Q4 2022 and has held it in 7 quarters since.
  • Marex Group's Affirm position peaked at $781K in Q1 2026.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.